Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device
Clinical trial NCT06192758 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06192758
- Sponsor
- Boston Scientific Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-15
- Primary completion
- 2028-01-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.